Your browser doesn't support javascript.
Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States.
Fisher, Kiva A; Olson, Samantha M; Tenforde, Mark W; Self, Wesley H; Wu, Michael; Lindsell, Christopher J; Shapiro, Nathan I; Files, D Clark; Gibbs, Kevin W; Erickson, Heidi L; Prekker, Matthew E; Steingrub, Jay S; Exline, Matthew C; Henning, Daniel J; Wilson, Jennifer G; Brown, Samuel M; Peltan, Ithan D; Rice, Todd W; Hager, David N; Ginde, Adit A; Talbot, H Keipp; Casey, Jonathan D; Grijalva, Carlos G; Flannery, Brendan; Patel, Manish M; Feldstein, Leora R.
  • Fisher KA; CDC COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Olson SM; CDC COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Tenforde MW; CDC COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Self WH; Epidemic Intelligence Service, CDC, Atlanta, GA, USA.
  • Wu M; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
  • Lindsell CJ; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Shapiro NI; CDC COVID-19 Response Team, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
  • Files DC; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
  • Gibbs KW; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Erickson HL; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
  • Prekker ME; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Steingrub JS; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
  • Exline MC; Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA.
  • Henning DJ; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
  • Wilson JG; Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA.
  • Brown SM; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
  • Peltan ID; Hennepin County Medical Center, Minneapolis, MN, USA.
  • Rice TW; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
  • Hager DN; Hennepin County Medical Center, Minneapolis, MN, USA.
  • Ginde AA; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
  • Talbot HK; Baystate Medical Center, Springfield, MA, USA.
  • Casey JD; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
  • Grijalva CG; Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Flannery B; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
  • Patel MM; University of Washington Medical Center, Seattle, WA, USA.
  • Feldstein LR; Influenza Vaccine Effectiveness in the Critically Ill (IVY) Network, USA.
Influenza Other Respir Viruses ; 15(3): 345-351, 2021 05.
Article in English | MEDLINE | ID: covidwho-1010931
ABSTRACT

BACKGROUND:

Symptoms of mild COVID-19 illness are non-specific and may persist for prolonged periods. Effects on quality of life of persistent poor physical or mental health associated with COVID-19 are not well understood.

METHODS:

Adults aged ≥18 years with laboratory-confirmed COVID-19 and matched control patients who tested negative for SARS-CoV-2 infection at outpatient facilities associated with 11 medical centers in the United States were interviewed to assess symptoms, illness duration, and health-related quality of life. Duration of symptoms, health-related quality of life measures, and days of poor physical health by symptoms experienced during illness were compared between case patients and controls using Wilcoxon rank-sum tests. Symptoms associated with COVID-19 case status were evaluated by multivariable logistic regression.

RESULTS:

Among 320 participants included, 157 were COVID-19 cases and 163 were SARS-CoV-2 negative controls. Loss of taste or smell was reported by 63% of cases and 6% of controls and was strongly associated with COVID-19 in logistic regression models (adjusted odds ratio [aOR] = 32.4; 95% confidence interval [CI], 12.6-83.1). COVID-19 cases were more likely than controls to have experienced fever, body aches, weakness, or fatigue during illness, and to report ≥1 persistent symptom more than 14 days after symptom onset (50% vs 32%, P < .001). Cases reported significantly more days of poor physical health during the past 14 days than controls (P < .01).

CONCLUSIONS:

Differentiating COVID-19 from other acute illnesses will require widespread diagnostic testing, especially during influenza seasons. Persistent COVID-19-related symptoms may negatively affect quality of life, even among those initially presenting with mild illness.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Quality of Life / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Influenza Other Respir Viruses Journal subject: Virology Year: 2021 Document Type: Article Affiliation country: Irv.12832

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Quality of Life / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Influenza Other Respir Viruses Journal subject: Virology Year: 2021 Document Type: Article Affiliation country: Irv.12832